| Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naive social phobia patients MM Bergamaschi, RHC Queiroz, MHN Chagas, DCG De Oliveira, ... Neuropsychopharmacology 36 (6), 1219-1226, 2011 | 843 | 2011 |
| Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology OD Howes, R McCutcheon, O Agid, A De Bartolomeis, NJM Van Beveren, ... American Journal of Psychiatry 174 (3), 216-229, 2017 | 782 | 2017 |
| Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial F Palhano-Fontes, D Barreto, H Onias, KC Andrade, MM Novaes, ... Psychological medicine 49 (4), 655-663, 2019 | 634 | 2019 |
| Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report JAS Crippa, GN Derenusson, TB Ferrari, L Wichert-Ana, FLS Duran, ... Journal of psychopharmacology 25 (1), 121-130, 2011 | 576 | 2011 |
| Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug AW Zuardi, JAS Crippa, JEC Hallak, FA Moreira, FS Guimarães Brazilian journal of medical and biological research 39, 421-429, 2006 | 566 | 2006 |
| Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report FL Osório, RF Sanches, LR Macedo, RG Dos Santos, JP Maia-de-Oliveira, ... Brazilian Journal of Psychiatry 37, 13-20, 2015 | 514 | 2015 |
| Síndrome de burnout ou estafa profissional e os transtornos psiquiátricos TR Trigo, CT Teng, JEC Hallak Archives of Clinical Psychiatry (São Paulo) 34, 223-233, 2007 | 500 | 2007 |
| Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a SPECT study RF Sanches, F de Lima Osório, RG Dos Santos, LRH Macedo, ... Journal of clinical psychopharmacology 36 (1), 77-81, 2016 | 447 | 2016 |
| The psychedelic state induced by ayahuasca modulates the activity and connectivity of the default mode network F Palhano-Fontes, KC Andrade, LF Tofoli, AC Santos, JAS Crippa, ... PloS one 10 (2), e0118143, 2015 | 408 | 2015 |
| Cannabidiol for the treatment of psychosis in Parkinson’s disease AW Zuardi, JAS Crippa, JEC Hallak, JP Pinto, MHN Chagas, ... Journal of Psychopharmacology 23 (8), 979-983, 2009 | 405 | 2009 |
| Confiabilidade da" Entrevista Clínica Estruturada para o DSM-IV-Versão Clínica" traduzida para o português CM Del-Ben, JAA Vilela, JAS Crippa, JEC Hallak, CM Labate, AW Zuardi Brazilian Journal of Psychiatry 23, 156-159, 2001 | 373 | 2001 |
| Effects of cannabidiol in the treatment of patients with Parkinson’s disease: an exploratory double-blind trial MHN Chagas, AW Zuardi, V Tumas, MA Pena-Pereira, ET Sobreira, ... Journal of Psychopharmacology 28 (11), 1088-1098, 2014 | 368 | 2014 |
| Neuroimaging in social anxiety disorder: a systematic review of the literature MC Freitas-Ferrari, JEC Hallak, C Trzesniak, A Santos Filho, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 34 (4), 565-580, 2010 | 352 | 2010 |
| Effects of cannabidiol (CBD) on regional cerebral blood flow JAS Crippa, AW Zuardi, GEJ Garrido, L Wichert-Ana, R Guarnieri, ... Neuropsychopharmacology 29 (2), 417-426, 2004 | 348 | 2004 |
| Glutamate and the neural basis of the subjective effects of ketamine: a pharmaco–magnetic resonance imaging study JFW Deakin, J Lees, S McKie, JEC Hallak, SR Williams, SM Dursun Archives of general psychiatry 65 (2), 154-164, 2008 | 345 | 2008 |
| Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment IB Chaudhry, J Hallak, N Husain, F Minhas, J Stirling, P Richardson, ... Journal of psychopharmacology 26 (9), 1185-1193, 2012 | 319 | 2012 |
| Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the … RG Dos Santos, FL Osório, JAS Crippa, J Riba, AW Zuardi, JEC Hallak Therapeutic advances in psychopharmacology 6 (3), 193-213, 2016 | 302 | 2016 |
| Age and gender influence on maximal bite force and masticatory muscles thickness M Palinkas, MSP Nassar, FA Cecílio, S Siéssere, M Semprini, ... Archives of oral biology 55 (10), 797-802, 2010 | 294 | 2010 |
| Use of the Fonseca's questionnaire to assess the prevalence and severity of temporomandibular disorders in Brazilian dental undergraduates K Nomura, M Vitti, AS Oliveira, TC Chaves, M Semprini, S Siéssere, ... Brazilian dental journal 18, 163-167, 2007 | 293 | 2007 |
| Cannabidiol monotherapy for treatment-resistant schizophrenia AW Zuardi, JEC Hallak, SM Dursun, SL Morais, RF Sanches, RE Musty, ... Journal of Psychopharmacology 20 (5), 683-686, 2006 | 271 | 2006 |
